{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:16:00Z","timestamp":1768522560162,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.biochi.2010.06.025","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T00:26:22Z","timestamp":1278894382000},"page":"1379-1386","source":"Crossref","is-referenced-by-count":43,"title":["N\u025b-(carboxymethyl)lysine linkage to \u03b1-synuclein and involvement of advanced glycation end products in \u03b1-synuclein deposits in an MPTP-intoxicated mouse model"],"prefix":"10.1016","volume":"92","author":[{"given":"Yeong-Gon","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2010.06.025_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ilar.48.4.339","article-title":"Nonhuman primate models of Parkinson\u2019s disease","volume":"48","author":"Emborg","year":"2007","journal-title":"ILAR J."},{"key":"10.1016\/j.biochi.2010.06.025_bib2","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","article-title":"Neurochemical findings in the MPTP model of Parkinson\u2019s disease","volume":"108","author":"Schmidt","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biochi.2010.06.025_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1212\/WNL.41.5_Suppl_2.38","article-title":"Mitochondrial DNA and Parkinson\u2019s disease","volume":"41","author":"Monte Di","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.biochi.2010.06.025_bib4","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain\u00a0mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.biochi.2010.06.025_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(90)90131-R","article-title":"The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP)","volume":"117","author":"Carboni","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biochi.2010.06.025_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biochi.2010.06.025_bib7","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","article-title":"Lewy bodies","volume":"103","author":"Shults","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biochi.2010.06.025_bib8","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","article-title":"Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications","volume":"318","author":"Brownlee","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biochi.2010.06.025_bib9","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/diacare.15.12.1835","article-title":"Glycation products and the pathogenesis of diabetic complications","volume":"15","author":"Brownlee","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biochi.2010.06.025_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/rp.56.1.1","article-title":"Protein glycation, diabetes, and aging","volume":"56","author":"Ulrich","year":"2001","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.biochi.2010.06.025_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0026-0495(85)80008-1","article-title":"Protein glycosylation and the pathogenesis of atherosclerosis","volume":"34","author":"Cerami","year":"1985","journal-title":"Metabolism"},{"key":"10.1016\/j.biochi.2010.06.025_bib12","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.91.11.4766","article-title":"Advanced glycation end products contribute to amyloidosis in Alzheimer disease","volume":"91","author":"Vitek","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biochi.2010.06.025_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(96)00729-9","article-title":"Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease","volume":"737","author":"Castellani","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.biochi.2010.06.025_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00401-002-0523-y","article-title":"Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer\u2019s disease","volume":"104","author":"Dei","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biochi.2010.06.025_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0891-0618(00)00096-X","article-title":"Crosslinking of alpha-synuclein by advanced glycation endproducts\u2013an early pathophysiological step in Lewy body formation?","volume":"20","author":"M\u00fcnch","year":"2000","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.biochi.2010.06.025_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(01)02514-9","article-title":"Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans","volume":"319","author":"Castellani","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biochi.2010.06.025_bib17","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/jnr.21644","article-title":"Advanced glycation end products induce in vitro cross-linking of \u03b1 -synuclein and accelerate the process of intracellular inclusion body formation","volume":"86","author":"Shaikh","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biochi.2010.06.025_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbapap.2008.11.016","article-title":"The modification of \u03b1-synuclein by dicarbonyl compounds inhibits its fibril-forming process","volume":"1794","author":"Lee","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2010.06.025_bib19","doi-asserted-by":"crossref","first-page":"e9052","DOI":"10.1371\/journal.pone.0009052","article-title":"Ribosylation rapidly induces \u03b1 -synuclein to form highly cytotoxic molten globules of advanced glycation end products","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2010.06.025_bib20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/jb\/mvh193","article-title":"Conventional antibody against N\u025b-(carboxymethyl)lysine (CML) shows cross-reaction to N\u025b-(carboxyethyl)-lysine (CEL): immunochemical quantification of CML with a specific antibody","volume":"136","author":"Koito","year":"2004","journal-title":"J. Biochem."},{"key":"10.1016\/j.biochi.2010.06.025_bib21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/labinvest.3780294","article-title":"Immunohistochemical distribution and quantitative biochemical detection of advanced glycation end products in fetal to adult rats and in rats with streptozotocin-induced diabetes","volume":"81","author":"Ling","year":"2001","journal-title":"Lab. Invest."},{"key":"10.1016\/j.biochi.2010.06.025_bib22","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1042\/bst0311438","article-title":"Application of monoclonal antibody libraries for the measurement of glycation adducts","volume":"31","author":"Nagai","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biochi.2010.06.025_bib23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/15321810903188136","article-title":"Characterization of anti-advanced glycation end products antibodies to nonenzymatically lysine-derived and arginine-derived glycated products","volume":"30","author":"Choi","year":"2009","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.biochi.2010.06.025_bib24","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1111\/j.1440-1746.2008.05552.x","article-title":"Increased pentosidine, an advanced glycation end-product, in urine and tissue reflects disease activity in inflammatory bowel diseases","volume":"23","author":"Kato","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biochi.2010.06.025_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1320-5463.2002.01390.x","article-title":"Accumulation of imidazolone, pentosidine and N\u025b-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain","volume":"52","author":"Jono","year":"2002","journal-title":"Pathol. Int."},{"key":"10.1016\/j.biochi.2010.06.025_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/exnr.1997.6648","article-title":"Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice","volume":"148","author":"Bezard","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biochi.2010.06.025_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3940(97)00663-0","article-title":"Kinetics of nigral degeneration in a chronic model of MPTP-treated mice","volume":"234","author":"Bezard","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biochi.2010.06.025_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuint.2009.10.005","article-title":"Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration","volume":"56","author":"Jung","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biochi.2010.06.025_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jnr.10253","article-title":"Cytokines, chemokines, and cytokine receptors in human microglia","volume":"69","author":"Lee","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biochi.2010.06.025_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1602\/neurorx.2.1.129","article-title":"Tyrosine hydroxylase replacement in experimental Parkinson\u2019s disease with transvascular gene therapy","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.biochi.2010.06.025_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neulet.2008.11.049","article-title":"Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model","volume":"450","author":"Choi","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biochi.2010.06.025_bib32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.neuroscience.2004.04.043","article-title":"Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment","volume":"126","author":"Knyih\u00e1r-Csillik","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.biochi.2010.06.025_bib33","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1460-9568.2009.06657.x","article-title":"PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson\u2019s disease","volume":"29","author":"Schintu","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biochi.2010.06.025_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.33549\/physiolres.930430","article-title":"Advanced glycation end-products and the progress of diabetic vascular complications","volume":"53","author":"Jakus","year":"2004","journal-title":"Physiol. Res."},{"key":"10.1016\/j.biochi.2010.06.025_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2003.08.014","article-title":"Intervention against the Maillard reaction in vivo","volume":"419","author":"Monnier","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biochi.2010.06.025_bib36","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson\u2019s disease mutations accelerate \u03b1-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biochi.2010.06.025_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"\u03b1-synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biochi.2010.06.025_bib38","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"Vila","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biochi.2010.06.025_bib39","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.biochi.2010.06.025_bib40","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biochi.2010.06.025_bib41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","article-title":"Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson\u2019s disease","volume":"956","author":"Meredith","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.biochi.2010.06.025_bib42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1471-4159.2008.05651.x","article-title":"Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid","volume":"107","author":"Alvarez-Fischer","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.biochi.2010.06.025_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0891-5849(01)00570-6","article-title":"Active glycation in neurofibrillary pathology of Alzheimer disease: N\u025b-(carboxymethyl)lysine and hexitol-lysine","volume":"31","author":"Castellani","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biochi.2010.06.025_bib44","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.91.12.5710","article-title":"Advanced Maillard reaction end products are associated with Alzheimer disease pathology","volume":"91","author":"Smith","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biochi.2010.06.025_bib45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/374316b0","article-title":"Early AGEing and Alzheimer\u2019s","volume":"374","author":"Smith","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2010.06.025_bib46","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1523\/JNEUROSCI.23-26-08955.2003","article-title":"Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition","volume":"23","author":"Fornai","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biochi.2010.06.025_bib47","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1046\/j.1471-4159.2003.01952.x","article-title":"Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson\u2019s disease","volume":"86","author":"H\u00f6glinger","year":"2003","journal-title":"J. Neurochem."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908410002567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908410002567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T01:12:06Z","timestamp":1685668326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908410002567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0300908410002567"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2010.06.025","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}